Keeping an Eye on Key Support
Watch LLC, SHL, ASX and AMC as stocks that are trading on support.



Watch LLC, SHL, ASX and AMC as stocks that are trading on support.
The following group of stocks offer above average earnings growth, structural uptrends and are currently trading back on support levels that warrant closer attention.
ASX, AMC, BXB, JHX RHC, SEK, SHL, SUN and TWE.
More detail on the Investor Signals portfolio allocations and derivative overlay strategy will be provided in the October ASX top 50 Video Market Report.
Sonic Healthcare (SHL.ASX)
Amcor (AMC.ASX)
James Hardie (JHX.ASX)
Lend Lease (LLC.ASX)
Newcrest (NCM.ASX)
Resmed (RMD.ASX)
For more analysis on our recent buy recommendations and market stratagey, please keep an eye out for tomorrow’s mid-week market update video report. It will be sent out tomorrow morning as a blog post.
In today’s post we look at stocks recently commented on that require further attention, as profit taking is in sight or the entry level setups are now looking compelling.
NVT.ASX – Lift trailing stop loss to $5.25 support and retain profit target at $5.40
BLD.ASX – We had a buy recommendation on this at $6.20 and it has now rallied 10%+ to $6.85. Take profit on BLD and switch to JHX.
AMC.ASX – We see value in AMC at $15 only when complemented with a covered call strategy. Target is 7% capital growth, plus 2% from Feb div and 3% option premium. We have a six month time horizon on this trade.
ASX.ASX – Looks better value following the recent pullback and our algorithm engines are flagging a buy point.
The above charts summarise a few opportunities we’re watching. For further detail on our investment ideas, visit the monthly strategy piece or the recent mid week update.
If you have trouble locating the links to either of the above recordings, please email me.
leon@investorsignals.com
Amcor (AMC.ASX) acquired Sonoco’s North American rigid plastics operation for $280m. The acquisition will be EPS accretive by 2 – 3%. Amcor management expects to save $20m+ in synergy benefits.
FY17 Amcor should generate revenue of USD$9.7b, EBIT USD$1.1b, EPS growth of 8% and DPS of USD$0.44, placing the stock on a forward yield of 3.8%
We like AMC and see this as a suitable buy-write candidate for client portfolios. The stock trades ex-dividend tomorrow AUD$0.29.
Buy today and sell $17.00 calls into January.
Amcor (AMC.ASX) NPAT US$670m, EPS of $0.57 and final dividend of $0.22 CPS was inline with consensus. The numbers reflect a flat result on the same time last year, however, FY17 should see a return to underlying growth in the range of 5 – 7%.
FY17 revenue forecast of US$10b on EBIT of US$1.1b. EPS US$0.60 & DPS of US$0.55 placing AMC on a forward yield of 3.8%
We continue to see this as a buy on the dip story. Where we own AMC in the model from lower levels, we’ve been selling call options to enhance the yield.
Long AMC.ASX (update)
Amcor is now trading $15.75 or +10% from our buy range indicated in June. The nimble or leveraged trader should consider taking profit now, the investor may prefer to sell the $16.00 November call options for 50 -60 cent credit and keep exposure to the upcoming September dividend of approximately 28 cents.
Long AMC (update)
Reminder that I recommended buying AMC in the $14.25 to $15.00 range. It’s now trading $14.30 and you should begin accumulating today.
News on AMC.ASX
Packaging giant Amcor will take a hit of between $US170 million and $US200 million ($A227.49 million-$A267.63 million) in pre-tax profits over the 2017 and 2018 financial years, after announcing several measures to streamline its flexibles business.
Keep this one on your radar. It’s likely that a buy signal will occur following the aggressive sell-side response to the earnings news. This is a market darling and leveraged investors will be getting squeezed. An oversold condition will soon emerge and we expect to see a signal within the $14.25 to $15.00 range.
Or start a free thirty day trial for our full service, which includes our ASX Research.